Delivery Order SPE2DX22D0099-SPE2D826FAF5C
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,909.60 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by January 13, 2026 and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $151,468.20 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract that leverages the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,104.30 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is Conshohocken, Pennsylvania, with an...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,368.40 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract, designated as a non-set-aside competitive award, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under Amerisourcebergen's larger...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $27,771.66 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a continuation of the company's role as a critical federal medical supply vendor. The contract will be...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $4,880.86 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAF5CDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,157.17 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and calls for performance in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen's extensive federal contract portfolio demonstrates its capability as a critical vendor for military and veteran healthcare systems, supplying pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a significant IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, further establishing the organization's central role in federal pharmaceutical procurement and military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 1/11/26 |